Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

NEW ENGLAND JOURNAL OF MEDICINE(2023)

引用 23|浏览12
暂无评分
摘要
Nirsevimab to Prevent RSV Illness in InfantsNirsevimab, a monoclonal antibody targeting respiratory syncytial virus, protected against RSV-associated hospitalization and severe lower respiratory tract infection in term and late-preterm infants.
更多
查看译文
关键词
rsv,infants,prevention,late-preterm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要